Abstract
Gliosarcoma is a very uncommon primary brain malignancy and is considered a subtype of glioblastoma. It represents approximately 2% of cases classified as glioblastoma. Treatment of gliosarcoma follows the paradigm for glioblastoma with recommendations for a maximal allowable resection followed by post-operative radiation therapy to the operative bed with concurrent temozolomide.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
